These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 21877882

  • 1. Routine bone marrow biopsy is not necessary in the staging of patients with classical Hodgkin lymphoma in the 18F-fluoro-2-deoxyglucose positron emission tomography era.
    Richardson SE, Sudak J, Warbey V, Ramsay A, McNamara CJ.
    Leuk Lymphoma; 2012 Mar; 53(3):381-5. PubMed ID: 21877882
    [Abstract] [Full Text] [Related]

  • 2. 18F-FDG PET-CT imaging versus bone marrow biopsy in pediatric Hodgkin's lymphoma: a quantitative assessment of marrow uptake and novel insights into clinical implications of marrow involvement.
    Hassan A, Siddique M, Bashir H, Riaz S, Wali R, Mahreen A, Nawaz MK.
    Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1198-1206. PubMed ID: 28229191
    [Abstract] [Full Text] [Related]

  • 3. Role of bone marrow biopsy in staging of patients with classical Hodgkin's lymphoma undergoing positron emission tomography/computed tomography.
    Puccini B, Nassi L, Minoia C, Volpetti S, Ciancia R, Riccomagno PC, Di Rocco A, Mulè A, Toldo C, Sassone MC, Guariglia R, Filì C, Finolezzi E, Falorio S, Zanon S, Furlan A, Doa G, Zaja F, Fondazione Italiana Linfomi Postgraduate Master course.
    Ann Hematol; 2017 Jul; 96(7):1147-1153. PubMed ID: 28451805
    [Abstract] [Full Text] [Related]

  • 4. Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography/computed tomography-staged treatment-naive patients with Hodgkin lymphoma.
    El-Galaly TC, d'Amore F, Mylam KJ, de Nully Brown P, Bøgsted M, Bukh A, Specht L, Loft A, Iyer V, Hjorthaug K, Nielsen AL, Christiansen I, Madsen C, Johnsen HE, Hutchings M.
    J Clin Oncol; 2012 Dec 20; 30(36):4508-14. PubMed ID: 23150698
    [Abstract] [Full Text] [Related]

  • 5. [18F]Fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin's lymphoma.
    Purz S, Mauz-Körholz C, Körholz D, Hasenclever D, Krausse A, Sorge I, Ruschke K, Stiefel M, Amthauer H, Schober O, Kranert WT, Weber WA, Haberkorn U, Hundsdörfer P, Ehlert K, Becker M, Rössler J, Kulozik AE, Sabri O, Kluge R.
    J Clin Oncol; 2011 Sep 10; 29(26):3523-8. PubMed ID: 21825262
    [Abstract] [Full Text] [Related]

  • 6. (18)F-FDG PET/CT bone/bone marrow findings in Hodgkin's lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging.
    Moulin-Romsee G, Hindié E, Cuenca X, Brice P, Decaudin D, Bénamor M, Brière J, Anitei M, Filmont JE, Sibon D, de Kerviler E, Moretti JL.
    Eur J Nucl Med Mol Imaging; 2010 Jun 10; 37(6):1095-105. PubMed ID: 20204358
    [Abstract] [Full Text] [Related]

  • 7. Biopsy versus FDG PET/CT in the initial evaluation of bone marrow involvement in pediatric lymphoma patients.
    Cheng G, Chen W, Chamroonrat W, Torigian DA, Zhuang H, Alavi A.
    Eur J Nucl Med Mol Imaging; 2011 Aug 10; 38(8):1469-76. PubMed ID: 21505896
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Diagnostic performance of 18F-2-fluoro-2-deoxy-D-glucose PET/computerized tomography in identifying bone marrow infiltration in new patients with diffuse large B-cell lymphoma and Hodgkin lymphoma.
    Kandeel AA, Hussein M, Zidan L, Younis J, Edesa W, Alsayed Y.
    Nucl Med Commun; 2020 Mar 10; 41(3):269-279. PubMed ID: 31895758
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy.
    Teagle AR, Barton H, Charles-Edwards E, Dizdarevic S, Chevassut T.
    Acta Radiol; 2017 Dec 10; 58(12):1476-1484. PubMed ID: 28382828
    [Abstract] [Full Text] [Related]

  • 13. Predictive Value of FDG PET/CT Versus Bone Marrow Biopsy in Pediatric Lymphoma.
    Badr S, Kotb M, Elahmadawy MA, Moustafa H.
    Clin Nucl Med; 2018 Dec 10; 43(12):e428-e438. PubMed ID: 30358625
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multicentre study.
    Pelosi E, Penna D, Douroukas A, Bellò M, Amati A, Arena V, Passera R, Bisi G.
    Q J Nucl Med Mol Imaging; 2011 Aug 10; 55(4):469-75. PubMed ID: 21150862
    [Abstract] [Full Text] [Related]

  • 16. Role of F-18 FDG PET/CT in assessing bone marrow involvement in pediatric Hodgkin's lymphoma.
    Agrawal K, Mittal BR, Bansal D, Varma N, Srinivasan R, Trehan A, Manohar K, Kashyap R, Bhattacharya A, Marwaha RK.
    Ann Nucl Med; 2013 Feb 10; 27(2):146-51. PubMed ID: 23143537
    [Abstract] [Full Text] [Related]

  • 17. Loss of utility of bone marrow biopsy as a staging evaluation for Hodgkin lymphoma in the positron emission tomography-computed tomography era: a West of Scotland study.
    Hamilton R, Andrews I, McKay P, Leach M.
    Leuk Lymphoma; 2014 May 10; 55(5):1049-52. PubMed ID: 23915196
    [Abstract] [Full Text] [Related]

  • 18. Bone marrow FDG-PET/CT in Hodgkin lymphoma revisited: do imaging and pathology match?
    Adams HJ, Kwee TC, Fijnheer R, Dubois SV, Nievelstein RA, de Klerk JM.
    Ann Nucl Med; 2015 Feb 10; 29(2):132-7. PubMed ID: 25348549
    [Abstract] [Full Text] [Related]

  • 19. Italian Multicenter Study on Accuracy of 18F-FDG PET/CT in Assessing Bone Marrow Involvement in Pediatric Hodgkin Lymphoma.
    Cistaro A, Cassalia L, Ferrara C, Quartuccio N, Evangelista L, Bianchi M, Fagioli F, Bisi G, Baldari S, Zanella A, Pillon M, Zucchetta P, Burei M, Sala A, Guerra L, Guglielmo P, Burnelli R, Panareo S, Scalorbi F, Rambaldi I, Piccardo A, Garaventa A, Familiari D, Fornito MC, Lopci E, Mascarin M, Altini C, Ferrari C, Perillo T, Santoro N, Borsatti E, Rubini G.
    Clin Lymphoma Myeloma Leuk; 2018 Jun 10; 18(6):e267-e273. PubMed ID: 29739722
    [Abstract] [Full Text] [Related]

  • 20. Consistency of FDG-PET accuracy and cost-effectiveness in initial staging of patients with Hodgkin lymphoma across jurisdictions.
    Cerci JJ, Trindade E, Buccheri V, Fanti S, Coutinho AM, Zanoni L, Linardi CC, Celli M, Delbeke D, Pracchia LF, Pitela FA, Soares J, Zinzani PL, Meneghetti JC.
    Clin Lymphoma Myeloma Leuk; 2011 Aug 10; 11(4):314-20. PubMed ID: 21816369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.